| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA2114135
Max Phase: Preclinical
Molecular Formula: C19H17N3O4
Molecular Weight: 351.36
Molecule Type: Small molecule
Associated Items:
Representations
Canonical SMILES: Cc1ccc([C@H](C)NC(=O)C(=O)c2c[nH]c3ccc([N+](=O)[O-])cc23)cc1
Standard InChI: InChI=1S/C19H17N3O4/c1-11-3-5-13(6-4-11)12(2)21-19(24)18(23)16-10-20-17-8-7-14(22(25)26)9-15(16)17/h3-10,12,20H,1-2H3,(H,21,24)/t12-/m0/s1
Standard InChI Key: APNMXEIGSMLFMU-LBPRGKRZSA-N
Associated Targets(non-human)
GABA-A receptor; anion channel 910 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 351.36 | Molecular Weight (Monoisotopic): 351.1219 | AlogP: 3.44 | #Rotatable Bonds: 5 |
| Polar Surface Area: 105.10 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 11.22 | CX Basic pKa: | CX LogP: 3.60 | CX LogD: 3.60 |
| Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.32 | Np Likeness Score: -1.22 |
References
| 1. Primofiore G, Settimo FD, Taliani S, Marini AM, Novellino E, Greco G, Lavecchia A, Besnard F, Trincavelli L, Costa B, Martini C.. (2001) Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships., 44 (14): [PMID:11428922] [10.1021/jm010827j] |
Source
Source(1):